NASDAQ: BTCYBiotricity Inc Stock
$1.30-0.09 (-6.47%)
Updated Apr 25, 2024
BTCY Price
$1.30
Fair Value Price
N/A
Market Cap
$12.04M
52 Week Low
$0.70
52 Week High
$4.45
P/E
-0.74x
P/B
-0.43x
P/S
0.89x
PEG
N/A
Dividend Yield
N/A
Revenue
$11.63M
Earnings
-$14.58M
Gross Margin
65.5%
Operating Margin
-90.66%
Profit Margin
-132.3%
Debt to Equity
-1.16
Operating Cash Flow
-$7M
Beta
0.61
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
BTCY Overview
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BTCY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BTCY is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BTCY is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
BTCY's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more BTCY due diligence checks available for Premium users.
Be the first to know about important BTCY news, forecast changes, insider trades & much more!
BTCY News
Valuation
BTCY price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.74x
Industry
29.73x
Market
40.97x
BTCY price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-0.43x
Industry
3.71x
BTCY's financial health
Profit margin
Revenue
$3.0M
Net Income
-$2.8M
Profit Margin
-102.5%
BTCY's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
BTCY's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$5.5M
Liabilities
$32.2M
Debt to equity
-1.16
BTCY's short-term liabilities ($18.62M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BTCY's long-term liabilities ($13.59M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BTCY's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
BTCY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.3M
Investing
$0.0
Financing
$194.5k
BTCY's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
BTCY vs Medical Device Stocks
Biotricity Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.